Transdel Pharmaceuticals INC
SEC CIK 1360214 · TDLP.OB · last insider filing 2026-06-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Silvernail Lauren P | Director | filed 2024 - 2026 |
| Graves Adrienne L | Director | filed 2024 - 2026 |
| Sternberg Perry J. | Director | filed 2022 - 2026 |
| Baum Mark L | Director · Chief Executive Officer | filed 2012 - 2026 |
| Makary Martin A. | Director | filed 2022 - 2024 |
| Van Horn R. Lawrence | Director | filed 2020 - 2023 |
| Sparks Teresa | Director | filed 2020 - 2023 |
| Lindstrom Richard L MD | Director | filed 2015 - 2022 |
| Kammer Robert J | Director · Chief Executive Officer | filed 2012 - 2021 |
| Principi Anthony | Director | filed 2015 - 2020 |
| Austin Stephen G | Director | filed 2012 - 2020 |
| Nelson William H. | Director | filed 2014 - 2016 |
| Bassani August Shelby | Director | filed 2012 - 2014 |
| Kenny Peter C | Director | filed 2013 - 2013 |
| Abrams Jeffrey J | Director | filed 2007 - 2013 |
| Finnegan Paul | Director · Chief Medical Officer & COO | filed 2008 - 2013 |
| Brar Balbir | Director · Vice President | filed 2007 - 2013 |
| Bonfiglio John N | Director · President and CEO | filed 2010 - 2010 |
| Singh Juliet | Director · President and CEO | filed 2007 - 2009 |
| Thornley Anthony S | Director | filed 2007 - 2008 |
| Swann Lynn C | Director | filed 2008 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Shojaei Amir | CHIEF SCIENTIFIC OFFICER | filed 2025 - 2026 |
| Boll Andrew | VP, Accounting and Reporting | filed 2012 - 2026 |
| Sullivan Patrick William | CHIEF COMMERCIAL OFFICER | filed 2026 - 2026 |
| Mullery Francis William Jr | CEO, ImprimisRx | filed 2025 - 2025 |
| Pollard Randall E. | CHIEF ACCOUNTING OFFICER | filed 2025 - 2025 |
| Saharek John P. | President, ImprimisRx | filed 2015 - 2025 |
| Edwards Clayton D | Chief Operating Officer | filed 2017 - 2017 |
| Schupp Joachim PH | Chief Medical Officer | filed 2009 - 2013 |
| Nida Terry | Chief Business Officer | filed 2010 - 2010 |
| Lomoro John T | Chief Financial Officer | filed 2007 - 2009 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.